Treatment of Diabetic Ketoacidosis With Subcutaneous Insulin Aspart

Abstract

Our results indicate that the use of subcutaneous insulin aspart every 1 or 2 h represents a safe and effective alternative to the use of intravenous regular insulin in the management of patients with uncomplicated DKA.